One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” Q4 2025 ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill ...

Protagonist's pipeline leverages its proprietary Vectrix platform to target obesity, hematology, and inflammation. Find out ...

Protagonist Therapeutics has delivered strong Phase 3 data for both icotrokinra (psoriasis) and rusfertide (polycythemia vera), supporting blockbuster potential. Lucrative partnerships with Johnson & ...

London-based sales, finance and production company Protagonist Pictures has launched a boutique label on the eve of Cannes. Announced by Protagonist CEO Dave Bishop, Protagonist Picks will be led by ...

The biggest difference between Starfield and Fallout 4 is Bethesda's decision go with a silent protagonist this time around. But that wasn't always the case. In a recent interview with Polygon, lead ...

Alex Co has been writing about games for 15 years and running, and is a huge fan of online shooters and anything horror related. Ciri is the protagonist in The Witcher 4, replacing Geralt, as a ...